| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,348 |
8,549 |
$650K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,046 |
6,423 |
$335K |
| 36415 |
Collection of venous blood by venipuncture |
12,384 |
11,357 |
$47K |
| 99215 |
Prolong outpt/office vis |
442 |
412 |
$47K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
516 |
505 |
$41K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,548 |
3,459 |
$41K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,187 |
1,155 |
$34K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,185 |
1,152 |
$34K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
602 |
582 |
$34K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
303 |
271 |
$21K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
907 |
879 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
231 |
224 |
$17K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
194 |
187 |
$15K |
| 80306 |
|
738 |
716 |
$12K |
| 85027 |
|
2,089 |
2,008 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
907 |
887 |
$12K |
| 86780 |
|
999 |
968 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
425 |
415 |
$11K |
| 80053 |
Comprehensive metabolic panel |
1,215 |
1,173 |
$10K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
722 |
707 |
$9K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
479 |
462 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
254 |
230 |
$8K |
| 90686 |
|
929 |
915 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
860 |
842 |
$7K |
| 87653 |
|
235 |
232 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
93 |
89 |
$7K |
| 87210 |
|
1,403 |
1,338 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
922 |
880 |
$7K |
| 80061 |
Lipid panel |
504 |
489 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
206 |
204 |
$6K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
99 |
80 |
$5K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
150 |
148 |
$5K |
| 81025 |
|
565 |
548 |
$5K |
| 90715 |
|
260 |
256 |
$5K |
| 99000 |
|
360 |
352 |
$4K |
| 59025 |
Fetal non-stress test |
332 |
228 |
$4K |
| 86803 |
|
259 |
258 |
$4K |
| 91320 |
|
57 |
48 |
$3K |
| 86850 |
|
458 |
436 |
$3K |
| 76801 |
|
40 |
40 |
$3K |
| 90480 |
|
126 |
118 |
$3K |
| 99442 |
|
109 |
61 |
$3K |
| 87340 |
|
317 |
309 |
$2K |
| 76830 |
Ultrasound, transvaginal |
39 |
38 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
284 |
261 |
$2K |
| 99188 |
|
257 |
254 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
272 |
261 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
15 |
$2K |
| 86762 |
|
149 |
145 |
$1K |
| 82728 |
|
96 |
95 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
13 |
13 |
$1K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
144 |
134 |
$1K |
| 99443 |
|
35 |
20 |
$1K |
| 82950 |
|
302 |
298 |
$1K |
| 86900 |
|
401 |
381 |
$936.81 |
| 86901 |
|
401 |
381 |
$936.81 |
| 81001 |
|
368 |
355 |
$892.58 |
| 36416 |
|
331 |
255 |
$772.50 |
| 90746 |
|
12 |
12 |
$715.29 |
| 81003 |
|
417 |
397 |
$690.31 |
| 96127 |
|
158 |
156 |
$635.72 |
| 90682 |
|
17 |
13 |
$591.60 |
| 92551 |
|
99 |
97 |
$546.84 |
| 90670 |
|
128 |
128 |
$539.26 |
| 90656 |
|
42 |
42 |
$484.15 |
| 99441 |
|
31 |
19 |
$358.00 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
15 |
14 |
$329.49 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
127 |
125 |
$308.42 |
| 84703 |
|
261 |
250 |
$291.99 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
26 |
26 |
$214.66 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$199.44 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
91 |
66 |
$167.20 |
| 83550 |
|
17 |
17 |
$152.31 |
| 99173 |
|
114 |
111 |
$135.08 |
| 82043 |
|
12 |
12 |
$67.14 |
| 86140 |
|
12 |
12 |
$65.79 |
| 82952 |
|
29 |
25 |
$24.84 |
| X5622 |
|
178 |
173 |
$0.00 |
| 90685 |
|
13 |
12 |
$0.00 |
| 90698 |
|
120 |
120 |
$0.00 |
| 90697 |
|
38 |
38 |
$0.00 |
| 90677 |
|
26 |
26 |
$0.00 |